Please assess the completion status of the following clinical trial:

Trial Title: Fluorescence Angiography: Planning and Monitoring of Perforator Flaps

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* perforator flap reconstruction whatever the indication (cancer, trauma, malformations). The main targets are the fibula flaps, anterolateral thigh flaps and inferior epigastric flaps~* consenting patient~Exclusion Criteria:~* known indocyanine green allergy~* pregnant woman, parturient woman or nursing woman

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- add-on fluorescence angiography (Type: EXPERIMENTAL): The surgeon will prescribe the usual morphological assessment of the proposed flap:~* CT angiography for an anterolateral thigh flap or an epigastric inferior flap~* A Doppler ultrasonography for a fibula flap.~In addition to the usual radiological technique used to locate the perforating arteries, the patient will have a fluorescence angiography prior to surgery, another just after the end of surgery and then one every six hours during the next 4 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).